103 results
Page 5 of 6
6-K
EX-10.1
w95hswluzfelse6
17 May 19
Current report (foreign)
5:20pm
424B5
lqcq7jzi6f85d0y
17 May 19
Prospectus supplement for primary offering
5:19pm
424B5
ldsqip
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-5.1
e890r jq6h3q
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
t4ymtb4o2ka fg
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-99.1
dtkzp2 aozefu
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-1.1
1391b lt7uc0595tq28
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-4.1
jkq 1fm761knahdedxtm
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
20-F/A
EX-4.3
tyqh qwaxm6d2hs
11 Oct 17
Annual report (foreign) (amended)
12:00am
20-F
t1oucna1oers5a
25 Mar 15
Annual report (foreign)
12:00am
20-F
EX-4.18
4xz 802uk7zbnmi
25 Mar 15
Annual report (foreign)
12:00am
S-8
EX-5.1
b22co q2cw
3 Mar 15
Registration of securities for employees
12:00am
S-8
EX-4.4
1vve lkj04oel71j
3 Mar 15
Registration of securities for employees
12:00am